Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein

Atherosclerosis

Volumn 216, Issue 1, 2011, Pages 54-58

  Van De Parre, Tim J L ^a   Guns, Pieter Jan D F ^a   Fransen, Paul ^a   Martinet, Wim ^a   Bult, Hidde ^a   Herman, Arnold G ^a   De Meyer, Guido R Y ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Amyloid precursor protein; Atherogenesis; Atherosclerosis; Smooth muscle cells

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; COLLAGEN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THORACIC AORTA;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; AORTIC DISEASES; AORTIC VALVE; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS;

EID: 79955536509     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.032     Document Type: Article

References (19)

1. Lusis A.J. Atherosclerosis. Nature 2000, 407(6801):233-241.
2. Van Assche T., Hendrickx J., Crauwels H.M., et al. Transcription profiles of aortic smooth muscle cells from atherosclerosis-prone and resistant regions in young apolipoprotein E-deficient mice before plaque development. J Vasc Res 2010, 48(1):31-42.
3. Reinhard C., Hébert S.S., De Strooper B. The amyloid-beta precursor protein: integrating structure with biological function. EMBO J 2005, 24(23):3996-4006.
4. Jans D.M., Martinet W., Van De Parre T.J., et al. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease. Cardiovasc Hematol Disord Drug Targets 2006, 6(1):21-34.
5. Tibolla G., Norata G.D., Meda C., et al. Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. Atherosclerosis 2010, 210(1):78-87.
6. Ring S., Weyer S.W., Kilian S.B., et al. The secreted β-amyloid precursor protein ectodomain APPsα is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci 2007, 27(29):7817-7826.
7. Saitoh T., Sundsmo M., Roch J.M., et al. Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell 1989, 58(4):615-622.
8. Kockx M.M., De Meyer G.R.Y., Buyssens N., et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 1998, 83(4):378-387.
9. Karaulana E., Gramatikoff K., Milev P. Amyloid precursor protein might be a receptor for basic fibroblast growth factor. Int J Neurosci 1992, 66(1-2):93-95.
10. Shea T.B., Amyloid precursor protein as a glial-derived growth factor. Trends Neurosci 1994, 17(8):338-339.
11. Austin S.A., Combs C.K. Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice. Neurobiol Aging 2010, 31(11):1854-1866.
12. Sondag C.M., Combs C.K. Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J Biol Chem 2004, 279(14):14456-14463.
13. Smith C.C. Stimulated release of the beta-amyloid protein of Alzheimer's disease by normal human platelets. Neurosci Lett 1997, 235(3):157-159.
14. Kockx M.M., Cromheeke K.M., Knaapen M.W.M., et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23(3):440-446.
15. De Meyer G.R.Y., De Cleen D.M., Cooper S., et al. Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res 2002, 90(11):1197-1204.
16. Ylä-Herttuala S., Luoma J., Nikkari T., et al. Down's syndrome and atherosclerosis. Atherosclerosis 1989, 76(2-3):269-272.
17. Corsi M.M., Dogliotti G., Pedroni F., et al. Adipocytokines in Down's syndrome, an atheroma-free model: role of adiponectin. Arch Gerontol Geriatr 2009, 48(1):106-109.
18. Corsi M.M., Dogliotti G., Pedroni F., et al. Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway. Neuro Endocrinol Lett. 2006, 27(6):773-778.
19. Mei Z., Situ B., Tan X., et al. Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons. Brain Res 2010, 1348:165-173.